Louis Boon

26.9k total citations · 2 hit papers
376 papers, 17.7k citations indexed

About

Louis Boon is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Louis Boon has authored 376 papers receiving a total of 17.7k indexed citations (citations by other indexed papers that have themselves been cited), including 255 papers in Immunology, 71 papers in Oncology and 51 papers in Epidemiology. Recurrent topics in Louis Boon's work include Immune Cell Function and Interaction (123 papers), Immunotherapy and Immune Responses (95 papers) and T-cell and B-cell Immunology (94 papers). Louis Boon is often cited by papers focused on Immune Cell Function and Interaction (123 papers), Immunotherapy and Immune Responses (95 papers) and T-cell and B-cell Immunology (94 papers). Louis Boon collaborates with scholars based in Netherlands, Belgium and United States. Louis Boon's co-authors include Jon D. Laman, Ferry Cornelissen, Erik Lubberts, Anne‐Marie Mus, Errol P. Prens, Edwin F. Florencia, Jane S.A. Voerman, Marius Kant, Leslie van der Fits and Kingston H. G. Mills and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Louis Boon

368 papers receiving 17.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

2009 1.6k citations Louis Boon, Jon D. Laman et al. profile →
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

2011 541 citations Louis Boon et al. Nature Immunology profile →

Peers

Countries citing papers authored by Louis Boon

Since Specialization

Citations

This map shows the geographic impact of Louis Boon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Boon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Boon more than expected).

Fields of papers citing papers by Louis Boon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Boon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Boon. The network helps show where Louis Boon may publish in the future.

Co-authorship network of co-authors of Louis Boon

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Boon. A scholar is included among the top collaborators of Louis Boon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Boon. Louis Boon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthetic High‐Throughput Microarrays of Peptidoglycan Fragments as a Novel Sero‐Diagnostic Tool for Patient Antibody Profiling 2025 ·Angewandte Chemie International Edition ·(unknown), (unknown), Manuel G. Ricardo, Peter H. Seeberger, Yue Wang, Gerald B. Pier, Detlef Schuppan, Louis Boon, Jan Maarten van Dijl, Maria C. Bolling, Girbe Buist, Felix F. Loeffler, Jon D. Laman	1
2	Peptidoglycan accumulates in distinct brain regions and cell types over lifetime but is absent in newborns 2024 ·Brain Behavior and Immunity ·(unknown), Heidrun Kuhrt, Aline Rifflet, Karsten Winter, Louis Boon, Ruth M. Stassart, Erik Nutma, Jinte Middeldorp, (unknown), Ivo G. Boneca, Ingo Bechmann, Jon D. Laman	3
3	Targeting conserved TIM3 ⁺ VISTA ⁺ tumor-associated macrophages overcomes resistance to cancer immunotherapy 2024 ·Science Advances ·Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S. Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, (unknown), (unknown), (unknown), Maarten Jacquemyn, (unknown), Louis Boon, Susan Schlenner, Sabine Tejpar, Dirk Daelemans, Massimiliano Mazzone, Abhishek D. Garg	22
4	Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13) 2023 ·Autoimmunity Reviews ·Xavier Bossuyt, Jean‐Baptiste Vulsteke, Jan Van Elslande, Louis Boon, (unknown), (unknown), Glynis Frans, (unknown), Sébastien Carpentier, Sabine Tejpar, Hans Wildiers, Daniël Blockmans, Ellen De Langhe, Pieter Vermeersch, Rita Derua	4
5	T helper 2 cells control monocyte to tissue-resident macrophage differentiation during nematode infection of the pleural cavity 2023 ·Immunity ·Conor M. Finlay, (unknown), Lili Zhang, Brian H. K. Chan, Jesuthas Ajendra, Alistair Chenery, (unknown), Irem Kaymak, Emma L. Houlder, Syed Murtuza Baker, Ben Dickie, Louis Boon, Joanne E. Konkel, Matthew R. Hepworth, Andrew S. MacDonald, Gwendalyn J. Randolph, Dominik Rückerl, Judith E. Allen	25
6	Ablation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression 2022 ·Frontiers in Immunology ·(unknown), (unknown), Louis Boon, Andreas Kloetgen, Aikaterini Hatzioannou, Panayotis Verginis	20
7	Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice 2022 ·Nature Communications ·Rachael M. Zemek, Wee Loong Chin, Vanessa S. Fear, Ben Wylie, Thomas Casey, (unknown), Caitlin M. Tilsed, Louis Boon, Belinda B. Guo, Anthony Bosco, Alistair R. R. Forrest, Michael Millward, Anna K. Nowak, Richard Lake, Timo Lassmann, W. Joost Lesterhuis	25
8	Trichuris muris infection drives cell-intrinsic IL4R alpha independent colonic RELMα+ macrophages 2021 ·PLoS Pathogens ·Ruth Forman, Larisa Logunova, (unknown), Kelly Wemyss, Iris Mair, Louis Boon, Judith E. Allen, Werner Müller, Joanne L. Pennock, Kathryn J. Else	7
9	Lipocalin 2 modulates dendritic cell activity and shapes immunity to influenza in a microbiome dependent manner 2021 ·PLoS Pathogens ·Martin L. Watzenboeck, Barbara Drobits, Sophie Zahalka, Anna-Dorothea Gorki, (unknown), (unknown), Anastasiya Hladik, Karin Lakovits, Gabriel Richard, (unknown), Birgit Strobl, Gijs A. Versteeg, Louis Boon, Philipp Starkl, Sylvia Knapp	12
10	An intrinsic role of IL-33 in Treg cell–mediated tumor immunoevasion 2019 ·Nature Immunology ·Aikaterini Hatzioannou, Aggelos Banos, (unknown), (unknown), (unknown), Maren Köhne, Kristian Händler, Louis Boon, Ana Henriques, Vasiliki Koliaraki, Panagiotis Georgiadis, Jérôme Zoidakis, Aikaterini Termentzi, Marc Beyer, Triantafyllos Chavakis, Dimitrios T. Boumpas, Aristotelis Tsirigos, Panayotis Verginis	107
11	RASA1 mosaic mutations in patients with capillary malformation-arteriovenous malformation 2019 ·Journal of Medical Genetics ·Nicole Revençu, (unknown), Marie Ravoet, Raphaël Helaers, Pascal Brouillard, (unknown), (unknown), Marion Gérard, Veronika Dvořáková, Alan D. Irvine, Louis Boon, Miikka Vikkula	46
12	Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell–Mediated Tumor Immunity 2018 ·Cancer Research ·Christian Büll, Thomas J. Boltje, Natasja Balneger, (unknown), Melissa Wassink, Jasper J. van Gemst, Victor R. L. J. Bloemendal, Louis Boon, Johan van der Vlag, Torben Heise, Martijn H. den Brok, Gosse J. Adema	202
13	Rapid screening of IgG quality attributes – effects on Fc receptor binding 2017 ·FEBS Open Bio ·(unknown), (unknown), David Egging, Peter J. Simons, Louis Boon, Richard B. M. Schasfoort, Michel H. M. Eppink	22
14	Antitumor Immunity Triggered by Melphalan Is Potentiated by Melanoma Cell Surface–Associated Calreticulin 2015 ·Cancer Research ·Aleksandra M. Dudek-Perić, Gabriela B. Ferreira, Angelika Muchowicz, Jasper Wouters, Nicole Prada, Shaun Martin, Santeri Kiviluoto, Magdalena Winiarska, Louis Boon, Chantal Mathieu, Joost van den Oord, Marguerite Stas, Marie‐Lise Gougeon, Jakub Gołąb, Abhishek D. Garg, Patrizia Agostinis	84
15	Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death 2014 ·Clinical Cancer Research ·Tetje C. van der Sluis, Suzanne van Duikeren, (unknown), Ekaterina S. Jordanova, Elham Beyranvand Nejad, (unknown), Louis Boon, Vincent T.H.B.M. Smit, Marij J.P. Welters, Ferry Ossendorp, Bob van de Water, Ramon Arens, Sjoerd H. van der Burg, Cornelis J.M. Melief	60
16	Radiotherapy Combined with the Immunocytokine L19-IL2 Provides Long-lasting Antitumor Effects 2014 ·Clinical Cancer Research ·Catharina M.L. Zegers, Nicolle H. Rekers, (unknown), Natasja G. Lieuwes, Ala Yaromina, Wilfred T.V. Germeraad, Lotte Wieten, Erik A.L. Biessen, Louis Boon, Dario Neri, Esther G.C. Troost, Ludwig J. Dubois, Philippe Lambin	79
17	Immunotherapy with PI3K Inhibitor and Toll-Like Receptor Agonist Induces IFN-γ+IL-17+ Polyfunctional T Cells That Mediate Rejection of Murine Tumors 2011 ·Cancer Research ·Neil A. Marshall, Karen Galvin, (unknown), Louis Boon, Rowan Higgs, Kingston H. G. Mills	82
18	Potent Antitumor Immunity Generated by a CD40-Targeted Adenoviral Vaccine 2011 ·Cancer Research ·Basav N. Hangalapura, Dinja Oosterhoff, Jan de Groot, Louis Boon, Thomas Tüting, Alfons J. van den Eertwegh, Winald R. Gerritsen, Victor W. van Beusechem, Alexander Pereboev, David T. Curiel, Rik J. Scheper, Tanja D. de Gruijl	26
19	Rapidly induced, T-cell–independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells 2007 ·Blood ·Shengqiao Li, (unknown), Yuan Lin, Dominique Bullens, Omer Rutgeerts, Jozef Goebels, (unknown), Louis Boon, Ahmad Kasran, Rita De Vos, (unknown), Mark Waer, An Billiau	32
20	IL-12-independent down-regulation of allergic airway inflammation in mice by agonistic anti-CD40 mAb 2002 ·Allergy ·Peter W. Hellings, Ahmad Kasran, Lut Overbergh, Chantal Mathieu, Louis Boon, Hubertine Heremans, Patrick Matthys, Jan Ceuppens	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact